SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
FONTEYNE PAUL R.

(Last) (First) (Middle)
C/O AMAG PHARMACEUTICALS, INC.
1100 WINTER STREET

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/08/2019
3. Issuer Name and Ticker or Trading Symbol
AMAG PHARMACEUTICALS, INC. [ AMAG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities beneficially owned 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Nancy R. Smith, attorney-in-fact 10/10/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY 
For Executing Forms 3, 4 and 5 
 
Know all by these present,that the undersigned hereby 
constitutes and appoints each of Joseph Vittiglio, Carolyn Rucci 
and Nancy Smith, signing singly, his true 
and lawful attorney-in-fact to: 
 
(1) execute for and on behalf of the undersigned,in the 
undersigneds capacity as an officer and/or director of 
AMAG Pharmaceuticals, Inc., or the Company, Forms 3, 4 and 5
(including any amendments thereto) in accordance with Section 
16(a) of the Securities Exchange Act of 1934,
as amended and the rules thereunder; 
 
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete 
the execution of any such Forms 3, 4 and 5 and the timely filing
of such forms with the United States Securities and Exchange 
Commission and any other authority; and 
 
(3) take any other action of any type whatsoever in connection 
with the foregoing which,in the opinion of such attorney-in-fact
may be of benefit to,in the best interest of,or legally required
by,the undersigned,it being understood that the documents 
executed by such attorney-in-fact on behalf of the undersigned 
pursuant to this Power of Attorney shall be in such form and 
shall contain such terms
 and conditions as such attorney-in-fact
may approve in his discretion. 
 
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform all and every act and thing
whatsoever requisite, necessary and proper to be done in the 
exercise of any of the rights and powers herein granted,as fully
to all intents and purposes as the undersigned might or could do
if personally present,with full power of substitution or revocation
hereby ratifying and confirming all that such attorney-in-fact, or
his substitute or substitutes, shall lawfully do or cause to be done
by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Company assuming, 
any of the undersigneds responsibilities to comply with Section 16
of the Securities Exchange Act of 1934, as amended. 
 
This Power of Attorney replaces in their entirety any and all 
prior powers of attorney executed by the undersigned with respect 
to the subject matters set forth herein, including any powers of 
attorney previously filed with the Securities and Exchange 
Commission. This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to file 
Forms 3, 4 and 5 with respect to the undersigneds holdings of and
transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact. 
 
IN WITNESS WHEREOF, the undersigned has caused this Power of 
Attorney to be executed this 8th day of October 2019. 
 
 
Signed: /s/ Paul Fonteyne   
Please Print: Paul Fonteyne